The Systemic Sclerosis Treatments Market growth is driven by increasing disease prevalence, improved diagnostic capabilities, and expanding therapeutic pipelines. Rising awareness among healthcare providers enables earlier detection, expanding the addressable patient population. Government funding for rare disease research accelerates clinical trial activity and regulatory approvals....